PT Bundamedik Tbk (IDX:BMHS)
Indonesia · Delayed Price · Currency is IDR 184.00
-1.00 (-0.54%)
Apr 9, 2026, 4:08 PM WIB
PT Bundamedik Tbk Revenue
In the year 2025, PT Bundamedik Tbk had annual revenue of 1.61T IDR with 3.84% growth. PT Bundamedik Tbk had revenue of 459.45B in the quarter ending December 31, 2025, with 15.52% growth.
Revenue
1.61T
Revenue Growth
+3.84%
P/S Ratio
0.99
Revenue / Employee
1.04B
Employees
1,555
Market Cap
1.59T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.61T | 59.66B | 3.84% |
| Dec 31, 2024 | 1.55T | 66.49B | 4.47% |
| Dec 31, 2023 | 1.49T | -170.49B | -10.28% |
| Dec 31, 2022 | 1.66T | -232.11B | -12.28% |
| Dec 31, 2021 | 1.89T | 742.66B | 64.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 8.84T |
| PT Medikaloka Hermina Tbk | 7.13T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT Famon Awal Bros Sedaya Tbk | 2.44T |
| PT Sarana Meditama Metropolitan Tbk | 1.86T |
| PT Murni Sadar Tbk | 1.36T |
| PT Kedoya Adyaraya Tbk | 469.59B |
| PT Metro Healthcare Indonesia Tbk | 439.75B |